IGC Pharma, Inc. lost $0.09 per diluted share in fiscal year 2025. This represents an increase of 59.1% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters IGC Pharma, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$0.09
YoY+59.1%
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2027, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
IGC EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was IGC Pharma, Inc.'s diluted earnings per share in fiscal year 2025?
IGC Pharma, Inc. lost $0.09 per diluted share in fiscal year 2025.
How fast is IGC Pharma, Inc.'s diluted earnings per share growing?
IGC Pharma, Inc. (IGC) diluted earnings per share rose by 59.1% year over year, from -$0.22 to -$0.09 in fiscal year 2025.
How has IGC Pharma, Inc.'s diluted earnings per share changed over the years?
Across the 15 fiscal years this page covers, IGC Pharma, Inc. (IGC) diluted earnings per share went from -$1.34 in fiscal year 2011 to -$0.09 in fiscal year 2025.
What was IGC Pharma, Inc.'s diluted earnings per share in the most recent quarter?
IGC Pharma, Inc. (IGC) reported -$0.03 in diluted earnings per share in Q1 2027. This represents a decrease of 50.0% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what IGC Pharma, Inc. (IGC) reported on that line in every period on record.
